272 related articles for article (PubMed ID: 16146103)
1. Oxazolidinones--a new class of broad-spectrum chemotherapeutics.
Sztanke K; Pasternak K; Sztanke M
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):335-41. PubMed ID: 16146103
[TBL] [Abstract][Full Text] [Related]
2. [Linezolid--novel antibiotic for the treatment of gram-positive bacterial infections].
Jankowski A; Stefanik W
Wiad Lek; 2006; 59(9-10):727-31. PubMed ID: 17338140
[TBL] [Abstract][Full Text] [Related]
3. Oxazolidinone antibiotics.
Diekema DJ; Jones RN
Lancet; 2001 Dec; 358(9297):1975-82. PubMed ID: 11747939
[TBL] [Abstract][Full Text] [Related]
4. Oxazolidinones: activity, mode of action, and mechanism of resistance.
Bozdogan B; Appelbaum PC
Int J Antimicrob Agents; 2004 Feb; 23(2):113-9. PubMed ID: 15013035
[TBL] [Abstract][Full Text] [Related]
5. Linezolid.
Narang M; Gomber S
Indian Pediatr; 2004 Nov; 41(11):1129-32. PubMed ID: 15591662
[TBL] [Abstract][Full Text] [Related]
6. Linezolid.
French G
Int J Clin Pract; 2001; 55(1):59-63. PubMed ID: 11219321
[TBL] [Abstract][Full Text] [Related]
7. [Linezolid, an agent from a new class of antibiotics].
Kuijper EJ; Schippers EF; Bernards AT
Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1577-81. PubMed ID: 15382556
[TBL] [Abstract][Full Text] [Related]
8. Have the oxazolidinones lived up to their billing? Future perspectives for this antibacterial class.
Nilius AM
Curr Opin Investig Drugs; 2003 Feb; 4(2):149-55. PubMed ID: 12669374
[TBL] [Abstract][Full Text] [Related]
9. [Linezolid: antibacterial activity, clinical efficacy and resistance].
Bourgeois-Nicolaos N; Piriou O; Butel MJ; Doucet-Populaire F
Ann Biol Clin (Paris); 2006; 64(6):549-64. PubMed ID: 17162258
[TBL] [Abstract][Full Text] [Related]
10. New drugs for Gram-positive uropathogens.
Wagenlehner FM; Naber KG
Int J Antimicrob Agents; 2004 Sep; 24 Suppl 1():S39-43. PubMed ID: 15364305
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of linezolid versus comparator therapies in Gram-positive infections.
Wilcox MH
J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii27-35. PubMed ID: 12730140
[TBL] [Abstract][Full Text] [Related]
12. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
Deville JG; Adler S; Azimi PH; Jantausch BA; Morfin MR; Beltran S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S158-63. PubMed ID: 14520141
[TBL] [Abstract][Full Text] [Related]
13. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
Wareham DW; Abbas H; Karcher AM; Das SS
J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
[TBL] [Abstract][Full Text] [Related]
14. The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials.
Dresser LD; Rybak MJ
Pharmacotherapy; 1998; 18(3):456-62. PubMed ID: 9620097
[TBL] [Abstract][Full Text] [Related]
15. Linezolid--a new option for treating gram-positive infections.
Batts DH
Oncology (Williston Park); 2000 Aug; 14(8 Suppl 6):23-9. PubMed ID: 10989821
[TBL] [Abstract][Full Text] [Related]
16. [Linezolid, the first oxazolidinone antibiotic].
Dutronc H; Bocquentin F; Galpérine T; Lafarie-Castet S; Dupon M
Med Mal Infect; 2005 Sep; 35(9):427-34. PubMed ID: 16297585
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of staphylococci to linezolid and other antimicrobial agents.
Poiată A; Tuchiluş C; Bădicuţ I; Grigore L; Buiuc D
Roum Arch Microbiol Immunol; 2002; 61(4):293-9. PubMed ID: 15055263
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo activities of DA-7867, a new oxazolidinone, against aerobic gram-positive bacteria.
Yoon EJ; Jo YW; Choi SH; Lee TH; Rhee JK; Yoo M; Shim MJ; Choi EC
Antimicrob Agents Chemother; 2005 Jun; 49(6):2498-500. PubMed ID: 15917554
[TBL] [Abstract][Full Text] [Related]
19. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
[TBL] [Abstract][Full Text] [Related]
20. Conformational constraint in oxazolidinone antibacterials. Synthesis and structure-activity studies of (azabicyclo[3.1.0]hexylphenyl)oxazolidinones.
Renslo AR; Jaishankar P; Venkatachalam R; Hackbarth C; Lopez S; Patel DV; Gordeev MF
J Med Chem; 2005 Jul; 48(15):5009-24. PubMed ID: 16033280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
